Viatris Inc.

Viatris Inc. is a global healthcare and pharmaceutical company that develops, manufactures, and distributes generic medicines, branded prescription drugs, biosimilars, and over-the-counter pharmaceuticals across various therapeutic areas. Headquartered in Canonsburg, Pennsylvania, the corporation was formed through the combination of Mylan and Pfizer's Upjohn division. The company's product portfolio includes well-known branded medications such as Lipitor, Norvasc, Lyrica, Viagra, Zoloft, Xanax, and Dymista. Viatris operates an extensive global manufacturing and commercial network serving patients in more than 165 countries and territories across North America, Europe, Asia-Pacific, and emerging markets. Its therapeutic focus covers cardiovascular health, central nervous system and anesthesia, oncology, immunology, gastroenterology, eye care, respiratory conditions, and infectious diseases. Beyond finished dosage pharmaceuticals, the organization provides active pharmaceutical ingredients and offers licensing, co-promotion, contract development, and clinical research collaborations. By combining generic formulations with established branded pharmaceuticals, Viatris supplies scalable treatments to healthcare systems, distributors, and pharmacies worldwide.